No longer trades. Fund positions are valued at its last close, $17.03 on Sep 23, 2026. View SEC filing
THERAVANCE BIOPHARMA INC
TBPH (THERAVANCE BIOPHARMA INC) is held by 109 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($77.6M), Vanguard Capital Management LLC ($30.1M), State Street Corp. ($22.6M).
Who's Trading
Latest move
Source dates: Price Sep 23, 2026 · Insiders Sep 28, 2026 · Activists Sep 25, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 4.6M(+6.2%) | $77.6M | 0.0% | — | 32 | |
Decreased | 1.8M(-0.7%) | $30.1M | 0.0% | — | 0 | |
Increased | 1.3M(+2.4%) | $22.6M | 0.0% | — | 29 | |
Decreased | 1.2M(-2.6%) | $20.8M | 0.0% | — | 0 | |
Increased | 1.2M(+24.3%) | $20.2M | 0.0% | — | 35 | |
Decreased | 1.1M(-1.7%) | $19M | 0.0% | — | 0 | |
Increased | 1M(+6.0%) | $17.7M | 0.0% | — | 30 | |
Increased | 985,848(+296.4%) | $16.8M | 0.0% | — | 46 | |
Increased | 705,202(+38.2%) | $12M | 0.0% | — | 37 | |
Increased | 506,668(+488.5%) | $8.6M | 0.0% | — | 44 | |
Decreased | 488,309(-36.1%) | $8.3M | 0.0% | — | 0 | |
Increased | 429,813(+48.5%) | $7.3M | 0.0% | — | 38 | |
Increased | 404,356(+9.1%) | $6.9M | 0.0% | — | 30 | |
Decreased | 394,158(-1.6%) | $6.7M | 0.0% | — | 0 | |
First report | 387,493 | $6.6M | 0.0% | +0.18% | 0 | |
Decreased | 339,960(-18.3%) | $5.8M | 0.0% | — | 0 | |
Increased | 321,154(+3.4%) | $5.5M | 0.0% | — | 28 | |
Increased | 272,234(+3.9%) | $4.6M | 0.0% | — | 28 | |
Increased | 221,846(+74.3%) | $3.8M | 0.0% | — | 40 | |
Unchanged | 208,783 | $3.5M | 0.0% | — | 0 |
Showing 1-20 of 121
| Insider | Trade | Traded |
|---|---|---|
| Winningham Rick E | Disp | |
| Miller Aine | Disp | |
| Sawaf Aziz | Disp | |
| Grimaud Brett A. | Disp | |
| Smaldone Alsup Laurie | Disp | |
| Grimaud Brett A. | Disp | |
| Winningham Rick E | Disp | |
| Weiss Asset Management LP | Other 7.5M sh | |
| Sawaf Aziz | Disp | |
| Farnum Rhonda | Disp |
| Filer | Stake | Filed |
|---|---|---|
| Weiss Asset Management LP | 0.0% | |
| Newtyn Management, LLC | 6.7% | |
| Madison Avenue International LP | 17.7% | |
| Weiss Asset Management LP | 14.5% | |
| Newtyn Management, LLC | 8.5% | |
| BlackRock, Inc. | 6.5% |
TBPHTHERAVANCE BIOPHARMA INCContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about TBPH
Who owns TBPH?
109 institutional investors held TBPH on June 30, 2026, led by BlackRock, Inc. ($77.6M), Vanguard Capital Management LLC ($30.1M) and State Street Corp. ($22.6M).
How many hedge funds hold TBPH?
109 institutional investors reported TBPH in their 13F filings for the quarter ended June 30, 2026, $374.6M in all. 5 of them are rated Elite.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer